In RA specifically, a few mechanisms matter most: They turn down the inflammatory supply from fat tissue
Here's what you need to know: Medicare Coverage (Effective Mid-2026) Following the November 2025 Trump administration agreements, Medicare will cover GLP-1 medications for obesity with: $50 monthly copay for eligible patients $245 government cost (down from $1,000+ list prices) Medicare Eligibility Requirements: BMI over 27 with prediabetes OR established cardiovascular disease, OR BMI over 30 with uncontrolled hypertension, kidney disease, or heart failure, OR BMI over 35 (severe obesity) Medicaid Coverage States can opt into $245 monthly pricing for all covered uses
It moves the conversation away from a one-size-fits-all diagnosis toward more personalized care
At the heart of this approach are your mitochondria the powerhouses of your cells that fuel energy, metabolism, and repair
The patent remained remained unchallenged and unused by Eli Lilly until its expiry
Future research will focus on the benefit of tirzepatide in patients with chronic kidney disease and non-alcoholic fatty liver disease